Erratum to "The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial" [Contraception 2009;80:133-41] (DOI:10.1016/j.contraception.2009.02.006);The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial

Contraception

Volumn 80, Issue 2, 2009, Pages 133-141

  Meirik, Olav ^a,b   Rowe, Patrick J ^c   Peregoudov, Alexandre ^a   Piaggio, Gilda ^a   Petzold, Max ^d  

^a WORLD BANK   (United States)

^b Instituto Chileno de Medicina Reproductiva   (Chile)

^c Nordic School of Public Health ^*

^d NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

Author keywords

Frameless copper IUD; GyneFix; Paragard; Randomized clinical trial; TCu380A

Indexed keywords

COPPER INTRAUTERINE DEVICE; GYNEFIX; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE REMOVAL; ECTOPIC PREGNANCY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; MULTICENTER STUDY; NORMAL HUMAN; OUTCOME ASSESSMENT; PAIN; PELVIC INFLAMMATORY DISEASE; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL;

EID: 67651240838     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.01.007     Document Type: Erratum

References (13)

1. World Health Organization. Mechanism of action, safety and efficacy of intrauterine devices. Report of a WHO Scientific Group. Technical Report Series 753 (1987), World Health Organization, Geneva
2. Wildemeersch D., Van der Pas H., Thiery M., Van Kets H., Parewijck W., and Delbarge W. The copper-fix IUD: a new concept in IUD technology. Adv Contracep 4 (1988) 197-205
3. UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction: IUD Research Group. The TCu380A IUD and the frameless IUD "the FlexiGard": interim three-year data from an international multicenter trial. Contraception 52 (1995) 77-83
4. O'Brien PA, Marfleet C. Frameless versus classical intrauterine device for contraception. Cochrane Database of Systemic Reviews 2005, Issue 1. Art. No. CD003282. DOI: 10.102714651858.CD003282.pub.2 [Accessed 21 July 2008].
5. UNDP/UNFPA/WHO/World Bank, Special Programme of Research, Development, Research Training in Human Reproduction: and Task Force on the Safety and Efficacy of Fertility Regulating Methods. The TCu 380A, TCu 220C, Multiload 250 and Nova T IUDs at 3, 5 and 7 years of use - Results from three randomized multicenter trials. Contraception 42 (1990) 142-158
6. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction. Long-term reversible contraception: twelve years of experience with the TCu380A and TCu220C. Contraception 56 (1997) 341-352
7. Machin D., and Campell M.J. Statistical tables for the design of clinical trials (1987), Blackwell, Oxford
8. Farley T.M.M. Life-table methods for contraceptive research. Stat in Med 5 (1986) 475-489
9. Farley T.M.M., Rosenberg M.J., Powe P.J., Jian-Hua C.h.e.n., and Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339 (1992) 785-788
10. Sivin I. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol 78 (1991) 291-298
11. Dennis J., Webb A., and Kishen M. Expulsions following 1000 GyneFix insertions. J Fam Plann Reprod Health Care 27 (2001) 135-138
12. Wu S., Hu J., and Wildemeersch D. Performance of the frameless GyneFix and the TCu380A IUDs in a three-year multicenter randomized comparative trial in parous women. Contraception 61 (2000) 91-98
13. Wildemeersch D. New frameless and framed intrauterine devices and systems - an overview. Contraception 75 6 Suppl (2007) S82-S92